With the exception of 1996, when California first legalized medical cannabis, or 2012, when Colorado and Washington became the first states to legalize recreational pot, 2016 was probably marijuana’s best year ever.
When 2016 began, medical marijuana was legal in 23 states, and recreational weed could be purchased legally by adults 21 and up in four states. By year’s end, 28 states had legalized medicinal cannabis (two of which did so entirely through the legislative process), while the number of recreation-legal states had doubled to eight. Among those was California, which on its own is one of the largest economies in the world. Once the recreational business is ramped up, California is expected to generate $1 billion or more in added annual tax and licensing revenue from marijuana.
Changing perceptions of pot among the public is a big reason marijuana has flourished in recent years. Gallup, which conducts somewhat regular surveys on the public’s opinion of weed, has shown that in roughly 20 years, the percentage of respondents who want to see marijuana legalized nationally has more than doubled to 60% from 25%.
What’s next for marijuana with Sessions as attorney general?
The industry is facing a brand-new challenge in 2017: the appointment of Senator Jeff Sessions (R-Al.) as the nation’s next Attorney General.
Sessions is an ardent opponent of the legalization of marijuana. In a Senate drug hearing last April, Sessions cited a 20% increase in the number of traffic deaths in certain states where marijuana has been legalized as a reason the drug is a problem. Furthermore, Sessions has blamed the Obama administration’s relaxed marijuana policies for reversing what he believes was a positive hostility toward illegal drugs, including pot, that began during the Reagan years.
Perhaps the biggest uncertainty to face the marijuana industry in 2017 and beyond is what will happen once Donald Trump takes office and Sessions becomes the nation’s attorney general. Though there are a handful of possible scenarios, three seem most likely.
Most likely: The status quo continues
Though the appointment of Sessions should rightly strike fear in pro-legalization enthusiasts and among the marijuana industry, Sessions also has to contend with two key elements.
First, the public is overwhelmingly behind the idea of legalizing pot. Gallup’s poll shows that 6 in 10 Americans favor the full legalization of weed, while a CBS News poll from 2015 found that 84% of Americans favor the nationwide legalization of medical cannabis. Scaling back state-level pot laws now could be a devastating blow to the Republican Party’s popularity when so many Americans’ views on cannabis have changed over the past two decades.
The other factor here is that Donald Trump has come out on a few occasions during his campaigning to support the legalization of medical cannabis nationally. His opinion on recreational cannabis could be construed as mixed, with Trump advocating more of a wait-and-see approach, but he’s been clear about his stance that medical marijuana should be federally legal.
Can Trump convince a Republican congress to legalize medical marijuana? My guess is probably not, since many of the states that continue to hold cannabis as illegal on all levels are run by Republicans lawmakers. However, Sessions could have difficultly swaying Trump to make any changes to the current status quo given Trump’s campaign opinions and a desire not to anger a majority of the public. More than likely, the status quo of state-level legalization and regulation will remain intact.
Second most likely: Restrictions on new states, status quo continues for existing legal states
A second possibility, though I would put the likelihood of this happening pretty far behind the first scenario, is that Sessions could put the kibosh on state-level legalizations for new states, at least when it comes to recreational marijuana. Under such a scenario, the eight existing legal marijuana states would serve as something of a guinea pig for Congress to monitor before deciding whether or not to allow additional states to legalize.
Banning new states from legalizing pot would be a modest win for Sessions, but I don’t believe he could convince Congress or Trump to disallow the state-level legalization of medical marijuana in any of the remaining 22 states that haven’t legalized (should they decide to do so). Even though the Food and Drug Administration and Drug Enforcement Agency don’t recognize cannabis as having medically beneficial qualities, a number of university research studies have observed benefits from either marijuana itself or its cannabinoids. Plus, with so many people favoring the legalization of medical cannabis, cutting off access to medical pot could be negative publicity that Trump and his cabinet simply don’t need.
Third most likely: Recreational pot legalization is taken off the table at the state level
A third scenario, which is probably the least likely of the bunch, is that Sessions manages to convince Trump and a conservative Congress to remove the hands-off approach when it comes to recreational marijuana. In other words, this scenario would allow states that have legalized medical cannabis to keep their dispensaries intact, but it would shut down the recreational sale of pot in the eight legal states.
For Sessions, this would probably represent his greatest victory as attorney general, given his stance on marijuana. Of course, it’s also the least likely given the heat Congress and Trump would take from both the marijuana industry and the American public. In order for Sessions to succeed in pulling the cord on recreational marijuana, he would need to present some unequivocal evidence demonstrating the dangers of recreational marijuana to society. Traffic fatality data could potentially help his case, but he’d likely need far more to sway Trump and Congress.
Uncertainty begets caution
There’s little denying the huge dollar potential behind the steady expansion of the marijuana industry. According to investment company Cowen & Co., the legal pot industry could be worth $50 billion in a decade. These figures are certainly juicy enough to entice investors to take a shot on the pot industry.
Unfortunately, the appointment of Sessions, even if the status quo remains, makes investing in marijuana far too risky.
Aside from Sessions likely looking to scale back the marijuana industry by any means possible, pot businesses are set to face ongoing inherent disadvantages. For example, marijuana companies have limited access to basic banking services since most banks fear federal prosecution at some point in the future for dealing with pot businesses. Being forced to deal solely with cash is a security concern and an expansion inhibitor.
Additionally, marijuana businesses are stuck paying tax on their gross profits instead of net profits because they’re disallowed from taking normal corporate income tax deductions. Neither of these disadvantages is expected to change with Sessions as attorney general.